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Summary
 
Oxidized low-density lipoprotein (oxLDL) is considered one of the principal effectors of
atherogenesis. To explore mechanisms by which oxLDL affects human mononuclear phago-
cytes, we incubated these cells in medium containing oxLDL, acetylated LDL (acLDL), or na-
tive LDL, or on surfaces coated with these native and modified lipoproteins. The presence of
soluble oxLDL, acLDL, or native LDL in the medium did not stimulate H
 
2
 
O
 
2
 
 secretion by
macrophages. In contrast, macrophages adherent to surfaces coated with oxLDL secreted three-
to fourfold more H
 
2
 
O
 
2
 
 than macrophages adherent to surfaces coated with acLDL or native
LDL. Freshly isolated blood monocytes secreted little H
 
2
 
O
 
2
 
 regardless of the substrate on
which they were plated. H
 
2
 
O
 
2
 
 secretion was maximal in cells maintained for 4–6 d in culture
before plating on oxLDL-coated surfaces. Fucoidan, a known ligand of class A macrophage
scavenger receptors (MSR-A), significantly reduced macrophage adhesion to surfaces coated
with oxLDL or acLDL. Monoclonal antibody SMO, which blocks oxLDL binding to CD36,
did not inhibit adhesion of macrophages to oxLDL-coated surfaces but markedly reduced
H
 
2
 
O
 
2
 
 secretion by these cells. These studies show that MSR-A is primarily responsible for ad-
hesion of macrophages to oxLDL-coated surfaces, that CD36 signals H
 
2
 
O
 
2
 
 secretion by mac-
rophages adherent to these surfaces, and that substrate-bound, but not soluble, oxLDL stimu-
lates H
 
2
 
O
 
2
 
 secretion by macrophages.
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levated plasma levels of low-density lipoprotein (LDL)
predispose to atherosclerosis (1). Since native LDL is not
atherogenic, it is thought that atherogenesis results from the
formation and accumulation of oxidized LDL (oxLDL)
 
1
 
 in the
arterial intima (2). Indeed, accumulation of oxLDL (2) and of
lipoprotein degradation products (3, 4) are among the first
morphologically detectable changes in developing atheroscle-
rotic lesions. Products of modified lipoproteins stimulate en-
dothelial cells to produce monocyte chemoattractants, such as
monocyte chemoattractant protein 1 (MCP-1) and Gro-1
 
a
 
,
and these chemokines stimulate monocytes to adhere to, and
to enter, the subendothelial space (5, 6). There, the mono-
cytes mature into macrophages, take up lipids, and become
foam cells. Monocytes, macrophages, and foam cells together
comprise a majority of cells in fatty streaks, which are thought
to be the precursors of atherosclerotic plaques (7).
OxLDL interacts with monocytes and macrophages via
class A and class B scavenger receptors (MSR-A and MSR-B
[8–11]). MSR-A are homotrimeric proteins. There are two
types of MSR-A. Type I receptors contain a cysteine-rich
domain at their COOH (exofacial) terminus, whereas type II
receptors do not. Both type I and II class A receptors medi-
ate endocytosis of acetylated LDL (acLDL) and oxLDL (8).
Macrophages also express MSR-B. MSR-B are a struc-
turally heterogeneous family of proteins that includes
CD36 (11). In addition to macrophages, CD36 is found on
platelets (12) and microvascular endothelial cells in some,
but not all, organs (13, 14). CD36 mediates endocytosis of
oxLDL but not of acLDL (15).
 
1
 
Abbreviations used in this paper:
 
 acLDL, acetylated low-density lipoprotein;
DiI, 1,1
 
9
 
-dioctadecyl-3,3,3
 
9
 
,3
 
9
 
-tetramethylindocarbocyanine perchlor-
ate; HRP, horseradish peroxidase; KRBG-A, Krebs Ringer buffer with
glucose and albumin; MSR, macrophage scavenger receptors; oxLDL,
oxidized low-density lipoprotein. 
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Roles for Scavenger Receptor A and CD36 in Macrophage H
 
2
 
O
 
2
 
 Secretion
 
Monocytes from humans genetically deficient in CD36
have a decreased capacity to take up oxLDL (16). Mice
with targeted disruption of MSR-A and of apolipoprotein
E genes develop smaller atherosclerotic lesions than wild-
type mice (17). These findings implicate both MSR-A and
MSR-B in the metabolism of modified lipoproteins and
link MSR-A to the pathogenesis of atherosclerosis.
Monocytes and macrophages secrete reactive oxygen spe-
cies when they adhere via MSR-A to surfaces bearing fibril-
lar 
 
b
 
-amyloid, a ligand for these receptors (18). H
 
2
 
O
 
2
 
 se-
creted by these cells could oxidize LDL trapped in the
subendothelium, and both oxLDL and H
 
2
 
O
 
2
 
 have been
shown to affect gene expression in macrophages (19, 20),
smooth muscle cells (21), and endothelial cells (22). We
have examined the effects of soluble and substrate-bound
oxLDL, acLDL, and native LDL on monocyte/macrophage
adhesion, chemotaxis through Matrigel, and secretion of
H
 
2
 
O
 
2
 
, and the effects of antibodies that block the ligand-
binding domain of CD36 on macrophage H
 
2
 
O
 
2
 
 secretion.
Our findings extend those reported previously (23) by com-
paring the effects of soluble versus substrate-bound oxLDL,
acLDL, and native LDL on macrophage H
 
2
 
O
 
2
 
 secretion.
 
Materials and Methods
 
Materials.
 
Krebs Ringer buffer with glucose (KRB-G) con-
tained 145 mM NaCl, 4.86 mM KCl, 0.45 mM CaCl
 
2
 
, 1.22 mM
MgSO
 
4
 
, 5.7 mM Na
 
2
 
HPO
 
4
 
, and 5.5 mM glucose, pH 7.35.
KRBG-A was KRB-G with 1 mg/ml BSA (Sigma Chemical
Co., St. Louis, MO). PD buffer was as described (24). 5 mM
EDTA (Sigma Chemical Co.) was added to buffers in adhesion
experiments. Catalase and anti–human CD36 mAb (SMO) were
from Sigma Chemical Co. Control antibody, MOPC104E
(mouse IgM 
 
g 
 
light chains), was from Organon Teknika Corp.,
Cappel Research Products (Durham, NC). Human LDL (density 
 
5
 
1.019–1.063 g/ml), DiI-labeled LDL, acLDL, and DiI-labeled
acLDL were from Intracel, Inc. (Issaquah, WA). OxLDL and
DiI-labeled oxLDL were prepared by incubating equal volumes
of EDTA-free LDL or DiI-labeled LDL in 50 
 
m
 
M CuSO
 
4
 
 for 12 h
at 37
 
8
 
C. OxLDL and DiI-oxLDL were dialyzed for 2 or more
hours versus sterile H
 
2
 
O to remove CuSO
 
4
 
, and stored in the
dark at 4
 
8
 
C for up to 4 wk before use. Calcein/AM and Pluronic
F-127 were from Molecular Probes, Inc. (Eugene, OR). Fetal
bovine serum was from GIBCO BRL (Gaithersburg, MD).
 
Macrophages.
 
Fresh buffy coats from healthy human volun-
teers were obtained from the New York Blood Center. The
buffy coat was centrifuged on Ficoll-Hypaque (density 1.077;
Sigma Chemical Co.) at 400 
 
g
 
 for 30 min at room temperature.
The major band, containing the mononuclear cells, was har-
vested, and the mononuclear cells were washed by centrifugation
three times using RPMI 1640 supplemented with 
 
l
 
-glutamine
(Fisher Scientific Co., Springfield, NJ), then resuspended in
RPMI complete medium (RPMI 1640 supplemented with 30%
heat-inactivated [56
 
8
 
C for 30 min] human ultra serum [Gemini
Bio-Products, Inc., Calabasas, CA], 100 U/ml penicillin G, and
100 
 
m
 
g/ml streptomycin sulfate [Celox Laboratories, St. Paul,
MN]). 2 
 
3 
 
10
 
7
 
 cells were placed into each 75-cm
 
2
 
 tissue culture
flask (Corning Inc., Corning, NY) and incubated for 2 h at 37
 
8
 
C in
an atmosphere containing 5% CO
 
2
 
 and 95% air. Nonadherent cells
were removed by washing, and the cell layer was incubated in
RPMI complete medium for 10 h at 37
 
8
 
C, at which time the me-
dium was removed and the macrophages were detached by wash-
ing with PD buffer (24) supplemented with 5 mM EDTA. The cells
were centrifuged, resuspended in RPMI complete medium, and
incubated in teflon beakers at 37
 
8
 
C in a 5% CO
 
2
 
/95% air atmo-
sphere until used for experiments. Cell viability was checked before
each experiment by trypan blue exclusion and was always 
 
.
 
95%.
 
Preparation of Lipoprotein-coated Surfaces.
 
Wells of a 96-well
flat-bottomed microtiter plate were coated with either oxLDL,
acLDL, or native LDL by adding 50 
 
m
 
l of H
 
2
 
O containing these
lipoproteins in amounts indicated in the figure legends, and allow-
ing the water to evaporate at room temperature for 
 
z
 
12 h in a ster-
ile hood. In all experiments, at least three wells were coated with
the indicated lipoprotein preparation for each time point assayed.
To determine the stability of adhesion of these lipoproteins to the
surface of the wells, multiple wells of a 96-well microtiter plate
were precoated with 100 
 
m
 
l of H
 
2
 
O containing 10 
 
m
 
g of DiI-
oxLDL, DiI-acLDL, or DiI-LDL, and allowed to dry for 
 
z
 
12 h.
Each well was filled with 100 
 
m
 
l of KRBG-A, the plates were in-
cubated for 10 min to 4 h at 37
 
8
 
C, and the KRBG-A in each well
was collected and assayed fluorometrically on a Cytofluor II cell
plate reader (25) to determine their content of DiI-oxLDL, DiI-
acLDL, or DiI-LDL. No significant DiI fluorescence above back-
ground was observed in any of these samples, indicating that the
DiI-labeled lipoproteins did not elute from the surface of the wells.
 
Chemotaxis.
 
Chemotaxis was assayed as described (26).
 
Adhesion Assay.
 
Macrophages, cultured for the periods indi-
cated in the figure legends, were washed, labeled with calcein/
AM for 40 min as described (27), washed three times with
KRBG-A, and resuspended at 2.5 
 
3 
 
10
 
5
 
 cells/ml in KRBG-A
containing 5 mM EDTA, and 100 
 
m
 
l of this suspension was
added to each well of a 96-well flat-bottomed microtiter plate
(Falcon; Becton Dickinson Labware, Lincoln Park, NJ) which
had been precoated with 5 
 
m
 
g oxLDL, acLDL, or native LDL per
well, as described above. Cells were allowed to adhere for 90 min
at 37
 
8
 
C, washed twice gently with KRBG-A, and lysed by incu-
bation in 100 
 
m
 
l KRBG-A plus 10 
 
m
 
l of saponin solution (25 mg/
ml; Sigma Chemical Co.) for 40 min at room temperature. Calcein
fluorescence was read using a Cytofluor II cell plate reader as de-
scribed (27). In each experiment, we developed a standard curve
relating the number of adherent cells to calcein fluorescence by
plating varying numbers of calcein-labeled macrophages in tripli-
cate on uncoated 96-well microtiter plates for 90 min at 37
 
8
 
C. The
values obtained from these standard curves were used to calculate
the number of cells that adhered under each experimental condi-
tion. Control experiments showed that 17% of the calcein was re-
leased from monocytes/macrophages into the medium after 90 min
at 37
 
8
 
C. This percentage of dye release was taken into account in
calculating the total number of adherent cells.
 
H
 
2
 
O
 
2
 
 Secretion.
 
We used the method of De la Harpe and
Nathan (25) to measure H
 
2
 
O
 
2
 
 secretion. Scopoletin (Sigma
Chemical Co.) was dissolved at 1 mM in KRB and stored at 4
 
8
 
C.
Horseradish peroxidase (HRP; Sigma Chemical Co.) was dis-
solved in PD at 1,000 U/ml and stored at 
 
2
 
20
 
8
 
C. Immediately
before use, KRBG-A containing 20 
 
m
 
M scopoletin and 2 U/ml
HRP (KRBG-A, scopoletin/HRP) was prepared. Macrophages
were pelleted by centrifugation, resuspended at 2 
 
3 
 
10
 
6
 
 mac-
rophages per ml in KRBG-A, scopoletin/HRP, and 100 
 
m
 
l of
this suspension was placed into each well of a 96-well microtiter
plate precoated as described above with oxLDL, acLDL, or native
LDL. For experiments using control or anti-CD36 antibodies,
macrophages were preincubated for 10 min at room temperature
with the indicated antibody concentration in KRBG-A. The cells
were then added to wells coated with the indicated lipoprotein 
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preparation, and a sufficient volume of the scopoletin and HRP
stock solutions was added to bring the final concentrations of
these substances to 20 
 
m
 
M and 2 U/ml, respectively. In experi-
ments comparing effects of soluble versus surface-bound lipopro-
teins, cells were added to uncoated wells 
 
z
 
5 min before adding
the soluble lipoproteins. All experiments were done in triplicate
and repeated the number of times indicated in the figure legends
using macrophages from different donors.
 
Results
 
Effects of Unmodified and Chemically Modified LDL on Ad-
hesion and Migration of Monocyte-derived Macrophages.
 
In gen-
eral, monocytes that enter the subendothelial space of the
arterial intima do not become resident there. Rather, they
continue to migrate through the vessel wall. Thus, the ac-
cumulation of monocytes in the subendothelium, a distin-
guishing feature of nascent atherosclerotic lesions, reflects a
change in the usual behavior of these cells. Schmidt et al.
(28) and El Khoury et al. (18) reported that monocytes
become sessile when they encounter extracellular matrix
proteins bearing ligands (e.g., glycation products [28] and
b-amyloid fibrils [18], respectively) that bind to monocyte
plasma membrane receptors. Since oxLDL is a ligand for
both MSR-A and CD36, we reasoned that the presence of
oxLDL particles in the subendothelium might trap mono-
nuclear phagocytes at these sites. To test this idea, we
plated macrophages on surfaces coated with native LDL,
acLDL, or oxLDL and measured the number of cells that
adhered to these surfaces 90 min later.
Unlike integrins, scavenger receptors do not require diva-
lent cations to bind their ligands. Therefore, to distinguish
integrin receptor–mediated adhesion from scavenger receptor–
mediated adhesion, we plated macrophages on lipoprotein-
coated surfaces in divalent cation–deficient medium contain-
ing 5 mM EDTA (18). Monocyte-derived macrophages
adhered most efficiently to surfaces coated with oxLDL.
About 25 and 75% fewer macrophages adhered to surfaces
coated with acLDL or native LDL, respectively (Fig. 1). The
presence of divalent cations did not significantly enhance mac-
rophage adhesion to oxLDL- or acLDL-coated surfaces (data
not shown). These experiments indicate that as observed pre-
viously with fibrillar b-amyloid–coated surfaces (18), integrins
are not required for macrophage adhesion to oxLDL- or
acLDL-coated surfaces. In contrast, addition of fucoidan, a
polysaccharide ligand that competes for the ligand-binding do-
main of class A scavenger receptors (9, 18), blocked adhesion
of macrophages to oxLDL- or acLDL-coated surfaces by z62
and z38%, respectively (Fig. 1). The addition of 50 mg/ml of
soluble acLDL, a ligand for class A scavenger receptors (9),
reduced adhesion of macrophages to oxLDL-coated surfaces
by z50% (Fig. 1). Macrophage adhesion to surfaces coated
with either oxLDL or acLDL was unaffected by mAb SMO,
which specifically blocks the ligand-binding domain of CD36
(29), or by a control murine antibody of the same immuno-
globulin class (IgM) as SMO. These results show that integrins
and CD36 play an insignificant role in adhesion of macro-
phages to oxLDL- or acLDL-coated surfaces in the absence of
divalent cations. They strongly suggest that class A scavenger
receptors are the principal receptors responsible for adhesion of
macrophages to oxLDL- or acLDL-coated surfaces.
To determine whether the presence of oxLDL or acLDL
affects chemotaxis of mononuclear phagocytes, we used
chemotaxis chambers coated with Matrigel (26, 30) con-
taining oxLDL, acLDL, or native LDL. Monocytes, cul-
tured for 24 h, were placed in each chamber’s upper com-
partment, the chemoattractant FMLP was added to each
chamber’s lower compartment, and the chambers were incu-
bated at 378C for 24 h. We then measured the number of
cells that migrated into the lower compartment. Only 30% as
many macrophages migrated into the lower chamber
through Matrigel containing oxLDL or acLDL as through
Matrigel containing native LDL. Roughly equal numbers of
mononuclear phagocytes migrated into the lower chamber
through Matrigel and through Matrigel containing native
LDL (Fig. 2). Thus, the presence of oxLDL or acLDL mark-
edly inhibited macrophage chemotaxis through a three-
dimensional matrix containing basement membrane proteins.
Quinn et al. (31) reported that lipids, extracted from
oxLDL, block monocyte chemotaxis. Since acLDL was as
effective as oxLDL in blocking chemotaxis (Fig. 2), it
seems unlikely that oxidized lipids were responsible for the
inhibition of chemotaxis we observed in these experiments.
Effect of Soluble versus Surface-bound Native and Modified
LDL on H2O2 Secretion by Monocyte-derived Macrophages.
Products of oxidatively modified LDL have been identified
Figure 1. Effects of surface-bound native or modified LDL on macro-
phage adhesion. Human monocyte–derived macrophages (2.5 3 104 cells in
100 ml KRBG-A) that had been cultured for 5 d were added to each well of
a 96-well plate, which had been precoated with 5 mg of native, acLDL, or
oxLDL per well as described in Materials and Methods. Cells were allowed
to adhere for 90 min at 378C in the presence of KRBG-A plus 5 mM
EDTA alone or in KRBG-A plus 5 mM EDTA containing anti-CD36
mAb SMO (20 mg/ml), control antibody MOPC104E (20 mg/ml), or fu-
coidan (500 mg/ml). The number of adherent cells was determined as a
function of fluorescence intensity as described in Materials and Methods.
The data presented are the average 6 SEM of six experiments done in qua-
druplicate. Using a Student’s two-paired t test, statistical significance at the
level of **P , 0.001 was obtained for fucoidan inhibition of adhesion to
acLDL- or oxLDL-coated surfaces. Statistical significance at the level of
*P , 0.05 was obtained for acLDL inhibition of adhesion to acLDL- and
oxLDL-coated surfaces. Macrophage plating efficiency on native LDL–,
acLDL-, and oxLDL-coated surfaces was 16, 50, and 70%, respectively.2260 Roles for Scavenger Receptor A and CD36 in Macrophage H2O2 Secretion
in the matrix and within foam cells in atherosclerotic lesions
(32, 33). Although several pathways for LDL oxidation in
vivo have been suggested (34–39), the precise mechanisms
by which LDL becomes oxidized are unresolved. Mont-
gomery et al. (23) reported that neither soluble acLDL nor
soluble oxLDL stimulate H2O2 secretion by macrophages.
We have confirmed this result (Fig. 3 A [soluble oxLDL],
and data not shown [acLDL]). To test whether the presence
of native or modified lipoproteins on surfaces has a different
effect than soluble lipoproteins on H2O2 secretion by mac-
rophages, we compared H2O2 secretion by macrophages
plated on surfaces coated with oxLDL, acLDL, or native
LDL versus macrophages adherent to albumin-coated sur-
faces and incubated in medium containing the same amount
of soluble oxLDL, acLDL, or native LDL as contained on
the substrate. Macrophages adherent to surfaces coated with
10 mg oxLDL secreted approximately fourfold more H2O2
than macrophages adherent to surfaces coated with albumin
and incubated in medium containing 10 mg of soluble
oxLDL (Fig. 3 A). Macrophages plated on surfaces coated
with native LDL (Fig. 3, A and B) or with acLDL (Fig. 3 B)
produced only 25% of the amount of H2O2 as macrophages
plated on surfaces coated with oxLDL (Fig. 3 B). There were
no significant differences in the rates or amounts of H2O2
secreted by macrophages plated on acLDL-coated surfaces
versus native LDL-coated surfaces (Fig. 3 B), even though
approximately threefold more macrophages adhered to sur-
faces coated with acLDL than with native LDL (Fig. 1). We
derive two conclusions from these experiments: first, sur-
face-bound acLDL does not stimulate macrophages to
secrete H2O2; and second, surface-bound, but not soluble,
oxLDL stimulates macrophages to secrete H2O2.
Effects of Amounts of Substrate-adherent OxLDL and of
Monocyte Maturation on H2O2 Secretion. To determine whe-
ther the amount of oxLDL on the substrate affected H2O2
secretion, we plated macrophages on surfaces incubated with
0.1–10 mg oxLDL. Surfaces coated with .3 mg oxLDL in-
duced maximal H2O2 secretion (Fig. 4). Surfaces coated with
z1 mg oxLDL stimulated z50% maximal H2O2 secretion
(Fig. 4). The amount of H2O2 secreted by macrophages
plated on surfaces incubated with ,0.5 mg oxLDL was not
significantly different from the amount secreted by macro-
phages plated on surfaces coated with native LDL or acLDL
(compare Fig. 4 with Fig. 3, A and B, and Fig. 5).
Monocytes plated on acLDL- (not shown), oxLDL-, or
native LDL–coated surfaces immediately after isolation, and
macrophages derived from monocytes maintained in cul-
ture for 1–2 d, secreted very little H2O2 when plated on
native LDL– or oxLDL-coated surfaces (Fig. 5). As ex-
pected (18, 40), monocytes cultured for 1 d secreted sub-
stantial H2O2 in response to zymosan or phorbol esters
(data not shown), confirming that these cells were capable
of H2O2 secretion when suitably stimulated.
Monocytes that had matured in culture for 4–6 d before
plating secreted approximately three- to fourfold more
H2O2 when plated on surfaces coated with oxLDL than on
uncoated surfaces or on surfaces coated with native LDL
(Fig. 5). Macrophages cultured for 7 d or more before plat-
ing on oxLDL-coated surfaces secreted less H2O2 according
to the length of time beyond 7 d they were maintained in
culture before plating (Fig. 5).
Figure 2. Effects of matrix-bound native LDL, acLDL, or oxLDL on
chemotaxis of mononuclear phagocytes. Mononuclear phagocytes, iso-
lated and maintained in culture for 24 h as described in Materials and
Methods, were suspended at 2.5 3 106/ml in RPMI containing 0.1% hu-
man serum albumin (RPMI-A). 500 ml of this suspension was placed into
the upper chamber of each chemotaxis insert precoated with Matrigel
and, where indicated, 50 mg of native LDL, oxLDL, or acLDL. The bot-
tom chamber was filled with RPMI-A containing the chemoattractant
FMLP (1026 M), and the chambers were incubated at 378C for 24 h. The
number of cells in the bottom chamber was assayed as described (refer-
ence 26). The data presented are the average 6 SEM of two experiments
done in triplicate.
Figure 3. Surface-bound, but not soluble, oxLDL stimulates H2O2 se-
cretion by macrophages. (A) Macrophages (2 3 105 cells in 100 ml
KRBG-A), 4–7 d in culture, were plated and maintained in each well of
96-well microtiter plates for up to 3 h at 378C in KRBG-A containing
scopoletin/HRP. Each well was precoated with 10 mg of oxLDL or na-
tive LDL, or the medium contained 10 mg/100 ml oxLDL or native LDL.
H2O2 was measured as described in Materials and Methods. Data reported
are the average 6 SEM for H2O2 secreted in three experiments done in
triplicate. Statistical significance at the levels of *P , 0.05 using Student’s
two-paired t test in comparing substrate-bound oxLDL with soluble LDL.
(B) Macrophages (2 3 105 cells in 100 ml KRBG-A), 3–7 d in culture,
were plated and maintained for up to 3 h at 378C in each well of 96-well
microtiter plates in KRBG-A containing scopoletin/HRP. Wells were pre-
coated as indicated with 10 mg of native LDL (squares), oxLDL (circles), or
acLDL (triangles), as described in Materials and Methods. H2O2 was mea-
sured as in A and is the average 6 SEM of three experiments, each done in
triplicate. Statistical significance at the level of *P , 0.05 using Student’s
two-paired t test in comparing oxLDL with either native LDL or acLDL.2261 Maxeiner et al.
Variations in the Amounts of H2O2 Secreted by Macrophages
from Different Donors. As noted by Nakagawara et al. (40),
there was considerable variation in the absolute amount of
H2O2 secreted by mononuclear phagocytes from different
donors. To confirm that the results reported above were
indeed due to the effects of oxLDL-coated surfaces and not
to chance variations in H2O2 secretory capacity of cells
from different donors, we compared H2O2 secreted by
macrophages from 19 different donors when plated on sur-
faces coated with native LDL versus oxLDL. As shown in
Fig. 6, regardless of the absolute amount of H2O2 secreted
by macrophages from a specific donor, macrophages from
that donor consistently secreted approximately threefold
more H2O2 when plated on surfaces coated with oxLDL
than on surfaces coated with native LDL. Thus, the varia-
tion in absolute amounts of H2O2 secreted by cells from
different donors appears to reflect intrinsic differences in
the H2O2 secretory capacity of these cells and does not af-
fect the conclusion that surfaces coated with oxLDL stimu-
late significantly greater macrophage H2O2 secretion than
surfaces coated with native LDL.
Effects of Catalase and Anti-CD36 on Scopoletin Oxidation
by H2O2 Secreted by Macrophages Adherent to OxLDL-coated
Surfaces. Addition of catalase to the medium of macro-
phages plated on surfaces coated with oxLDL reduced sco-
poletin oxidation by z50% (Fig. 7). Catalase lowered by
z20% the small amount of scopoletin oxidized by macro-
phages plated on uncoated surfaces, native LDL–coated (Fig.
7), or acLDL-coated surfaces (not shown). In other control
experiments, catalase inhibited scopoletin oxidation by PMA-
stimulated macrophages by z50% (not shown). Thus, catalase
inhibited scopoletin oxidation to a similar extent, regardless of
whether the initiating stimulus was surface-bound oxLDL or
phorbol ester. These experiments confirm that the major pro-
portion of scopoletin oxidized by macrophages plated on
oxLDL-coated surfaces is due to H2O2 secreted by these cells.
MSR-A is expressed by freshly explanted monocytes,
and continues to be expressed as they differentiate into
macrophages (41). This is consistent with the finding that
MSR-A is the primary receptor responsible for adhesion of
monocytes (data not shown) and macrophages (Fig. 1) to
oxLDL-coated surfaces. However, the findings that mono-
nuclear phagocytes adherent to oxLDL-coated surfaces did
not secrete significant amounts of H2O2 above background
until day 3 of culture (Fig. 5) and that H2O2 secretion by
these cells diminished progressively after day 7 of culture
seemed inconsistent with a primary role for MSR-A in sig-
naling H2O2 secretion. CD36, a scavenger receptor known
to bind oxLDL and to signal H2O2 secretion in macro-
phages (42), is first expressed on day 2 of monocyte culture
and wanes after day 7 (11). Thus, the reported time course
Figure 4. Effect of amount of surface-bound oxLDL on H2O2 secre-
tion by macrophages. Macrophages (2 3 105 in 100 ml KRBG-A), 4–7 d
in culture, were plated and incubated for 2 h at 378C in each well of 96-
well microtiter plates precoated as indicated with 0.1–10 mg oxLDL.
H2O2 secretion was measured using scopoletin/HRP, as described for
Fig. 3 A. Each point is the average 6 SEM nmoles H2O2 secreted in two
to five experiments, each experiment done in triplicate.
Figure 5. Effect of in vitro maturation of mononuclear phagocytes on
H2O2 secretion stimulated by substrate-bound oxLDL or native LDL.
Macrophages, 0–15 d in culture, were plated and incubated for 2 h at
378C in 96-well flat-bottomed microtiter plates precoated with 5–10 mg
of oxLDL or native LDL, and H2O2 secretion was measured, all as de-
scribed for Fig. 3 A. Data are the average 6 SEM of two to five experi-
ments done in triplicate.
Figure 6. Variation in H2O2 secretion of macrophages from different
donors plated on surfaces coated with oxLDL versus native LDL. Mac-
rophages (2 3 105 in KRBG-A), 3–7 d in culture, were plated and incu-
bated for 2 h at 378C in 96-well microtiter plates precoated with 10 mg of
oxLDL or native LDL. Each point is the average nmoles H2O2 secreted in
19 experiments done in triplicate. The correlation line was calculated us-
ing the Origin 4.10 linear regression program.2262 Roles for Scavenger Receptor A and CD36 in Macrophage H2O2 Secretion
of CD36 expression appeared to be more closely correlated
with the onset and decline of H2O2 secretion by macro-
phages plated on oxLDL-coated surfaces (Fig. 5) than the
reported time course of MSR-A expression. Therefore, we
tested the effect of SMO, an antibody that blocks the inter-
action of oxLDL with CD36, on H2O2 secretion by macro-
phages adherent to oxLDL-coated surfaces. Anti-CD36 anti-
body inhibited scopoletin oxidation to about the same extent
as catalase (Fig. 8), whereas an isotype-matched control anti-
body (MOPC104E) was without effect (Fig. 8). The combi-
nation of anti-CD36 and catalase was no more effective in
blocking scopoletin oxidation by macrophages plated on
oxLDL-coated surfaces than anti-CD36 or catalase alone
(Fig. 8). As expected, fucoidan, which blocks macrophage
adhesion to oxLDL-coated surfaces by z58% (Fig. 1), also
inhibited by 75–80% H2O2 secretion by macrophages plated
on oxLDL-coated surfaces (data not shown). We conclude
that signals initiated by the interaction of CD36 with sub-
strate-bound oxLDL are responsible for the catalase-sensitive
H2O2 secreted by macrophages adherent to this substrate.
Discussion
The evidence that MSR-A play a central role in chronic
degenerative diseases such as atherosclerosis and Alzheimer’s
disease has been strengthened considerably by the reports
of Suzuki et al. (16) and El Khoury et al. (18). Suzuki et al.
(16) showed that apolipoprotein E–deficient mice whose
MSR-A had been genetically disrupted developed smaller
atherosclerotic lesions than mice with normal MSR-A
function. Similarly, El Khoury et al. (18) showed that
MSR-A mediates adhesion of microglial cells to fibrillar
b-amyloid, and that this adhesive interaction leads to the se-
cretion of reactive oxygen species by the microglial cells.
The findings reported here extend these reports (16, 18), and
provide new insights regarding three aspects of the behavior
and physiology of monocytes and macrophages in athero-
genesis.
Proposed Mechanism for the Retention of Mononuclear Phago-
cytes in the Arterial Intima at Sites of Nascent Atherogenesis.
The experiments reported here show that macrophages
adhere much more avidly to surfaces coated with acLDL or
oxLDL than to surfaces coated with native LDL (Fig. 1), and
that matrices containing acLDL or oxLDL markedly inhibit
macrophage chemotaxis. That macrophage adhesion to
oxLDL-coated surfaces was significantly inhibited by fu-
coidan (Fig. 1), a ligand for scavenger receptors, but not by an
mAb that blocks CD36 (Fig. 1), suggests that the macro-
phages adhere to the substrate via interactions of MSR-A
with matrix-bound acLDL or oxLDL. The capacity of acLDL
or oxLDL, but not of native LDL, to reduce by z70% mac-
rophage chemotaxis through Matrigel (Fig. 2) is consistent
with previous observations of El Khoury et al. (18) that
ligands for MSR-A block both spontaneous and chemoattrac-
tant-stimulated migration of mononuclear phagocytes.
Deposition of antibodies directed against basement
membrane proteins in the glomerular basement membrane
(43) leads to retention of mononuclear phagocytes in the
glomerulus. Presumably, this occurs because monocytes,
attracted to the glomerular basement membrane by com-
plement components (e.g., C5a), adhere via their Fc and
complement receptors to antibodies and complement com-
ponents deposited on the glomerular basement membrane,
and thereby become trapped at this site.
The findings reported here suggest that a similar adhesive
event, albeit mediated by MSR-A, leads to the trapping of
monocytes in the subendothelial space in nascent atheroscle-
rotic lesions. Oxidized and degraded lipoproteins are depos-
ited in the subendothelium before the accumulation of
monocytes at these sites (4). Oxidized lipoproteins stimulate
Figure 7. Effect of catalase on detection of H2O2 secreted by macro-
phages on oxLDL-coated surfaces. Macrophages (2 3 105 cells in 100 ml
KRBG-A), cultured for 3–5 d, were plated on precoated surfaces and in-
cubated in KRBG-A containing scopoletin/HRP and 1,800 U/ml cata-
lase (cat.) for 2 h at 378C. Each well of a 96-well microtiter plate was pre-
coated with 10 mg of native LDL or oxLDL, as indicated. H2O2 was
measured as described for Fig. 3 A. Each point is the mean 6 SEM
nmoles H2O2 from four experiments, each done in triplicate.
Figure 8. Effect of antibody directed against CD36 on H2O2 secretion
by macrophages on oxLDL-coated surfaces. Macrophages (2 3 105 cells
in KRBG-A), 6–7 d in culture, were preincubated with anti-CD36 mAb
(SMO, 10 mg/ml) or control antibody (MOPC104E, 10 mg/ml) for 10
min at room temperature before plating. Each point is the mean 6 SEM
nmoles H2O2 secreted in three experiments done in triplicate.2263 Maxeiner et al.
endothelial cells to express adhesion receptors for monocytes
(e.g., vascular cell adhesion molecule 1 [VCAM-1; reference
42]) and to secrete chemokines (5, 6), which stimulate
monocytes to adhere to and migrate into the subendothelial
space. Deposition of oxidized and degraded lipoproteins in
the subendothelial matrix of arteries creates ligands for
MSR-A at these sites. We suggest that interactions of MSR-A
with these matrix-associated ligands lead to trapping of
mononuclear phagocytes at sites of nascent atheroma forma-
tion, just as interactions of MSR-A with ligands on matrix-
bound b-amyloid fibrils inhibit monocyte migration (18).
Matrix-associated OxLDL Stimulates H2O2 Secretion by
Macrophages. Substrate-adherent phagocytes secrete H2O2
in larger amounts and for a more sustained period than
phagocytes in suspension (44). However, differences in cell
adhesion do not explain the differences in H2O2 secretion we
have observed. 75 and 25% as many macrophages adhered
to acLDL- or native LDL–coated surfaces, respectively, as to
oxLDL-coated surfaces (Fig. 1), yet macrophages adherent to
oxLDL-coated surfaces secreted z2.5–3-fold more H2O2
than macrophages adherent to acLDL- or native LDL–coated
surfaces (Fig. 3 A). Moreover, macrophages plated on surfaces
coated with native LDL or acLDL secreted approximately
equivalent amounts of H2O2 (Fig. 3 B), yet adhered in much
larger numbers to surfaces coated with acLDL. Thus, effi-
ciency of adhesion cannot account for the observed differ-
ences in H2O2 secretion by macrophages adherent to oxLDL-
versus acLDL-coated surfaces.
Several investigators have tested the effects of soluble na-
tive LDL and soluble oxLDL on H2O2 secretion by mono-
cytes and macrophages (23, 42). Those who used scopole-
tin/HRP to measure H2O2, such as Montgomery et al.
(23), reported that neither native nor modified LDL in so-
lution stimulated H2O2 production by these cells. We have
confirmed and extended their findings, as described above.
OxLDL, but not acLDL, is a ligand for CD36 (15). Our
studies show that mAb SMO, which is directed against
CD36, has no effect on macrophage adhesion to surfaces
coated with oxLDL (Fig. 1), but inhibits z55% of H2O2
production by macrophages plated on oxLDL-coated sur-
faces (Fig. 8). Thus, while MSR-A appears to be the prin-
cipal macrophage plasma membrane receptor that mediates
adhesion of macrophages to oxLDL-coated surfaces (Fig.
1), the interaction of CD36 with oxLDL on these surfaces
is required for H2O2 secretion by these cells.
Agents that cross-link CD36 are reported to stimulate
macrophages to secrete H2O2 (42). mAb SMO is an IgM,
and might be expected to cross-link CD36, thereby signal-
ing H2O2 secretion. But SMO does not stimulate H2O2 se-
cretion, it inhibits it (Fig. 8). Nonetheless, it is evident that
substrate-bound oxLDL is a powerful stimulus for H2O2
secretion, whereas soluble oxLDL is not.
Like SMO antibody, soluble oxLDL should be a polyva-
lent ligand for CD36. We suspect soluble oxLDL and SMO
antibody are ineffective in stimulating H2O2 secretion be-
cause they do not cause them to aggregate in the appropriate
orientation or together with other receptors (e.g., MSR-A).
mAbs directed against CD36 stimulate H2O2 secretion by
macrophages most efficiently when cross-linked by a sec-
ondary antibody (42). Assuming that adsorption of oxLDL to
the substrate produces multiple CD36 ligands in close appo-
sition to one another, substrate-adherent oxLDL may be
much more efficient than soluble oxLDL in cross-linking
CD36 with itself or with other scavenger-type receptors.
The Capacity of Macrophages Matured in Culture for 4–6 d to
Secrete H2O2 in Response to Substrate-bound OxLDL Is Corre-
lated with CD36 Expression. Freshly isolated monocytes,
and monocytes cultured for 1–2 d, secrete very little H2O2
when plated on oxLDL-coated substrates (Fig. 5). This very
low level of H2O2 secretion cannot be ascribed to the inabil-
ity of these immature cells to synthesize or secrete H2O2.
Nakagawara et al. (40) reported that freshly isolated blood
monocytes secrete nearly as much H2O2 in response to PMA
stimulation as monocyte-derived macrophages maintained in
culture for 3–5 d. Similarly, monocytes maintained in cul-
ture for 1 d secrete substantial amounts of H2O2 in response
to zymosan (data not shown, and reference 18). The studies
of Huh et al. (11) provide a possible explanation for the lack
of H2O2 secretion by freshly explanted monocytes plated on
substrates coated with oxLDL. They found little or no CD36
mRNA or protein in freshly isolated blood monocytes, but
noted markedly increased CD36 mRNA expression begin-
ning on day 2 of culture. They showed that CD36 mRNA
and protein levels were maximal from days 3 to 6 of culture,
and were substantially reduced in cells cultured for 7 d or
more. Thus, the chronology of CD36 expression parallels
very closely the one we observed for H2O2 secretion by
macrophages plated on oxLDL-coated surfaces (Fig. 5).
Ligands that block MSR-A, such as fucoidan, block mac-
rophage adhesion to oxLDL-coated surfaces. mAb SMO,
which inhibits the interaction of CD36 with oxLDL, blocks
Figure 9. Diagram summarizing proposed effects of CD36 on H2O2
secretion by macrophages adherent to surfaces coated with native LDL or
oxLDL. Macrophages adhere inefficiently to surfaces coated with native
LDL (Fig. 1). Native LDL does not engage CD36 or MSR-A (macro-
phage on left). Macrophages adhere efficiently to surfaces coated with
oxLDL (Fig. 1, and macrophages illustrated in center and on right).
MSR-A is the principal surface receptor that mediates macrophage adhe-
sion to oxLDL-coated surfaces (Fig. 1, and macrophage illustrated on
right). Engagement of CD36 by substrate-bound oxLDL signals H2O2 se-
cretion by macrophages (Fig. 8, and macrophage illustrated in center).
Antibodies that block interaction between CD36 and substrate-bound
oxLDL inhibit H2O2 secretion by macrophages adherent to oxLDL-
coated surfaces (Fig. 8, and macrophage illustrated on right).2264 Roles for Scavenger Receptor A and CD36 in Macrophage H2O2 Secretion
H2O2 secretion (Fig. 8) without affecting macrophage adhe-
sion to oxLDL-coated surfaces (Fig. 1). These findings suggest
that CD36 is the principal receptor that mediates H2O2 secre-
tion by macrophages adherent to oxLDL-coated surfaces, and
that MSR-A’s principal function is to promote cell adhesion
to these surfaces, as shown diagrammatically in Fig. 9.
Atherosclerotic lesions generally take decades to form
and the better portion of a human lifetime to reach clinical
significance. However, repetitive episodes of H2O2 secre-
tion by macrophages adherent to foci of matrix-bound
oxLDL, even at the leisurely pace signaled by CD36, may
over many years be sufficient to cause considerable tissue
damage. The system we describe here provides a model for
exploring the ways MSR-A and CD36 may cooperate in
signaling H2O2 secretion by mononuclear phagocytes, and
for assessing the roles of other secretory products of mono-
nuclear phagocytes (e.g., myeloperoxidase [36, 45]) in dam-
aging extracellular matrix proteins.
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